Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
3 CALLS ON FILE
EYPT
— EyePoint Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
MAR 4, 2026
REVENUE
$620000
-35.8%
NET MARGIN
-10904.7%
-4721.2 PTS
EPS
-$0.81
+4.7%
FREE CASH FLOW
-$66.0M
-9.8%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 3
OLDER CALL →